drug development Flashcards

1
Q

what are contract research organisations?

A

companies performing specific parts of the drug development process e.g. organising and running clinical trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is a lead compound?

A

molecule that acts specifically and selectively with protein target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are some optical approaches used to determine receptor activity?

A
  • measuring fluorescent emissions

- measuring light absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lead finding

A

high frequency + automated screens against chemical libraries
screen = performing assay on cloned gene generating target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is combinatorial chemistry?

A

synthesising multiple drugs that are derivatives of an initial molecule of interest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what does exploratory toxicology consist of?

A
  • general toxicity –> in silico and in vitro
  • preliminary genotoxicity - predict whether drug will cause dna mutations?
  • preliminary toxicity -> in vivo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what does exploratory safety consist of?

A
  • off target binding profile –> any unpredicted side effects?
  • preliminary cvs safety
  • preliminary cns safety - toxicity of small molecules that may enter cns?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe the ames test

A
  1. isolate strains of salmonella that cannot grow on a medium missing histamine
  2. apply drug on medium
  3. bacteria grows? - may have acquired mutation reversing effect
    so drug has potential to cause mutations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

arrhythmia biomarker

A

drugs that can bind to hERG k+ channel give rise to long QT syndrome in patients = electrophysiology
so drug can give rise to cardiac arrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how long do preclinical studies for small molecules take?

A

4-4.5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how long do preclinical studies for biomolecules take?

A

2-2.5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is exaggerated pharmacology

A

drug having a more extreme reaction than expected. relates to high specificity and effectiveness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is a cytokine storm?

A

massive immune reaction after injecting drug for 1st time

leads to massive organ failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the irwin activity screen for rats?

A
  • test if drug has entered cns and exerted any effects there

observing behaviour, respiratory rate, heart rate, muscle tone, motor coordination etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is a major metabolite

A

metabolite accounting for >10% of parent compound - may have to synthesise and test separately

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DEFINE: pharmacodynamics

A

study of the ability of a drug to exert its effect on intended target

17
Q

phase I of clinical development

A
8-20 healthy volunteers 
minimal dose 
how safe is the drug?
how well is the drug tolerated? - any side effects
pharmacokinetics
18
Q

phase II of clinical development

A

low 100s of patients/volunteers
test effectiveness
test concentration needed for effectiveness

19
Q

phase III of clinical development

A

lasts for several years
1000+ patients
multi centre + multinational
broadening patient groups to which the drug is administered
toxic side effects, tolerance, pharmacokinetics?
compare to standard treatment
randomised and blind trials

20
Q

what is hydromorphine?

A

narcotic painkiller

taking with alcohol -> respiratory depression -> overdose

21
Q

what are the causes of drugs failing to be registered?

A
  • not economically viable
  • drug metabolism and pharmacokinetics - decreased strength of drug
  • no improvement in efficacy in patients